Magnesium Supplementation in Solitary Kidney Patients

Risk Assessment Framework

• The key determinant for magnesium supplementation safety in solitary kidney patients is renal function, not kidney number, as a solitary kidney with normal function handles magnesium similarly to two kidneys 3
• Individuals with one kidney do not need to routinely limit magnesium supplementation, but must avoid it entirely if their creatinine clearance falls below 20 mL/min due to severe hypermagnesemia risk 1, 2

Clinical Algorithm for Solitary Kidney Patients

Step 1: Assess Renal Function

• Measure creatinine clearance or eGFR before any magnesium supplementation to assess renal function and determine the safety of supplementation 1, 2

Step 2: Determine Supplementation Safety

• For patients with a creatinine clearance greater than 30 mL/min, standard magnesium dosing can be used, with recommended daily doses of 320 mg for women and 420 mg for men 1
• For patients with a creatinine clearance less than 20 mL/min, magnesium supplementation is contraindicated due to the risk of severe hypermagnesemia 1, 2

Monitoring and Treatment

• Monitor patients for signs of hypermagnesemia, including loss of patellar reflexes, respiratory depression, hypotension, bradycardia, and cardiac conduction defects 2, 4
• Calcium gluconate or chloride can be used to reverse magnesium toxicity if it occurs 4

Practical Recommendations

• For solitary kidney patients with normal renal function, no routine limitation of magnesium supplementation is needed, and standard RDA guidelines can be followed 1
• For patients with any degree of renal impairment, renal function should be checked before supplementation, and magnesium should be avoided if creatinine clearance is less than 20 mL/min 1, 2